ExpansionPharma SRL
4.8 FTEThe score of ExpansionPharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +23 % Total assets +29 % Headcount (avg FTE) +860 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ExpansionPharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Aug 2026
- Year ended 31 Dec 2024filed on 20 May 2025
- Year ended 31 Dec 2023filed on 19 Aug 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 18 Aug 2022
ExpansionPharma's financial analysis
- Solvency66.3%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ExpansionPharma
ExpansionPharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0536.620.925
- VAT number
- BE0536620925
- Peppol
- Registered · 0208:0536620925 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Jul 2013
- Registered office
- 6700 Arlon
- Size
- Micro · 4.8 FTE
- Latest accounts
- 2025 · filed on 20 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
ExpansionPharma (SRL) has been based in Arlon since 2013, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 500,241 € and equity of €6.58m; its revenue is not published. With 4.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 66.3%, above the median of its sector (43.9%).
Companies similar to ExpansionPharma
Companies in the same business, of comparable size and area, outside its group.
- Devanthinic Pharma Activities of holding companies Seneffe · balance sheet €16.8m
- Wisli Invest Activities of holding companies Beernem · balance sheet €28.4m
- Silesam Activities of holding companies Roeselare · balance sheet €42.5m
- LES Pharmacies Benit-Dehaut-Rion Retail sale of pharmaceutical products Dour · balance sheet €14.7m
- BENU Retail sale of pharmaceutical products Wavre · balance sheet €84.1m
- Pharmacie Blondeau - Vander Cassyen Retail sale of pharmaceutical products Soignies · balance sheet €8.85m
- DE Service Apotheek Retail sale of pharmaceutical products Sint-Truiden · balance sheet €9.08m
- Bluestone Retail sale of pharmaceutical products Ixelles · balance sheet €9.57m
Frequently asked questions about ExpansionPharma
What is the revenue of ExpansionPharma?
ExpansionPharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ExpansionPharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0536620925 for ExpansionPharma, if the company is VAT-registered. Its company number (CBE) is 0536.620.925.
Where is the registered office of ExpansionPharma?
According to the CBE register, the registered office of ExpansionPharma is in 6700 Arlon.
What is the equity of ExpansionPharma?
At the close of the 2025 financial year, the equity of ExpansionPharma amounts to 6,578,762 €, a solvency of 66.3% of total assets.
How many people work at ExpansionPharma?
4.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ExpansionPharma?
The register lists 2 active mandates at ExpansionPharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ExpansionPharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →